Clinical Trial Update: OPT-CAD Score GUIded Dual ANtiplatelet De-esCalation Time [NA]

View source ↗

Summary

Trial NCT06216821 investigates OPT-CAD score-guided de-escalation timing for dual antiplatelet therapy in acute coronary syndrome and is currently recruiting at…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Snippet

Sponsor: Shenyang Northern Hospital | Conditions: Acute Coronary Syndrome | NA | Status: RECRUITING